{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:31:14Z","timestamp":1789601474604,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijregi.2025.100818","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T05:00:41Z","timestamp":1764392441000},"page":"100818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Epidemiology and control of hepatitis C virus infection in Brunei Darussalam: a retrospective cohort study"],"prefix":"10.1016","volume":"18","author":[{"given":"Kai Shing","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3301-7565","authenticated-orcid":false,"given":"Liling","family":"Chaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2025.100818_bib0001","series-title":"Global Hepatitis Report 2024 : Action for Access in Low- and Middle-Income Countries","year":"2024"},{"key":"10.1016\/j.ijregi.2025.100818_bib0003","unstructured":"Coalition for Global Hepatitis Elimination. Interim report: progress towards HBV and HCV elimination in the Western Pacific Region. Georgia: Coalition for Global Hepatitis Elimination, 2021."},{"key":"10.1016\/j.ijregi.2025.100818_bib0004","unstructured":"World Health Organization Western Pacific Region. Hepatitis data and statistics in the Western Pacific, https:\/\/www.who.int\/westernpacific\/health-topics\/hepatitis\/regional-hepatitis-data; n.d. [accessed 18 October 2022]."},{"key":"10.1016\/j.ijregi.2025.100818_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/2040622310384308","article-title":"Pegylated interferon and ribavirin treatment for hepatitis C virus infection","volume":"2","author":"Palumbo","year":"2011","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.ijregi.2025.100818_bib0006","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-147-10-200711200-00003","article-title":"Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis","volume":"147","author":"Veldt","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijregi.2025.100818_bib0007","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.cgh.2011.05.028","article-title":"Effects of a sustained virologic response on outcomes of patients with chronic hepatitis C","volume":"9","author":"Ng","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ijregi.2025.100818_bib0009","series-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030","year":"2022"},{"key":"10.1016\/j.ijregi.2025.100818_bib0010","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/v14071548","article-title":"Systematic review of hepatitis C virus prevalence in the WHO Western Pacific Region","volume":"14","author":"Iversen","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ijregi.2025.100818_bib0011","first-page":"16","article-title":"Hepatitis C virus infection in Brunei Darussalam: a genotypic study","volume":"2","author":"Chong","year":"2007","journal-title":"Brunei Darussalam J Health"},{"key":"10.1016\/j.ijregi.2025.100818_bib0012","first-page":"916","article-title":"Hepatitis C virus infection and haemodialysis: experience of a district general hospital in Brunei Darussalam","volume":"49","author":"Chong","year":"2008","journal-title":"Singapore Med J"},{"key":"10.1016\/j.ijregi.2025.100818_bib0013","first-page":"92","article-title":"Jalihal A. Chronic hepatitis C treatment response to combination therapy: Experience of RIPAS Hospital","volume":"6","author":"Chong","year":"2010","journal-title":"Brunei Int Med J"},{"key":"10.1016\/j.ijregi.2025.100818_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7189\/jogh.12.03083","article-title":"Development and implementation of a national mobile health application: a case study from Brunei","volume":"12","author":"Koh","year":"2022","journal-title":"J Glob Health"},{"key":"10.1016\/j.ijregi.2025.100818_bib0016","series-title":"Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework","year":"2016"},{"key":"10.1016\/j.ijregi.2025.100818_bib0017","series-title":"R: A language and environment for statistical computing","year":"2023"},{"key":"10.1016\/j.ijregi.2025.100818_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.103954","article-title":"HCV treatment initiation in the era of universal direct acting antiviral coverage \u2013 Improvements in access and persistent barriers","volume":"113","author":"Jiang","year":"2023","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.ijregi.2025.100818_bib0019","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijregi.2025.100818_bib0020","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1186\/s12889-023-16143-3","article-title":"Substantial impact of the COVID-19 pandemic on the reported number of diagnosed chronic hepatitis C virus infections in the Netherlands, 2019\u20132021","volume":"23","author":"den Boogert","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijregi.2025.100818_bib0021","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.amepre.2021.03.011","article-title":"Decreases in hepatitis C testing and treatment during the COVID-19 pandemic","volume":"61","author":"Kaufman","year":"2021","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ijregi.2025.100818_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27326","article-title":"Hepatitis C treatment initiation among US Medicaid enrollees","volume":"6","author":"Kapadia","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijregi.2025.100818_bib0023","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.45424","article-title":"Characteristics and treatment rate of patients with hepatitis C virus infection in the direct-acting antiviral era and during the COVID-19 pandemic in the United States","volume":"5","author":"Nguyen","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijregi.2025.100818_bib0024","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.livres.2022.12.003","article-title":"Prevalence, diagnosis, treatment, and associated factors of hepatitis C in the United States from 1999 to 2018: a population-based cross-sectional study","volume":"6","author":"Zhang","year":"2022","journal-title":"Liver Res"},{"key":"10.1016\/j.ijregi.2025.100818_bib0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12879-021-06336-9","article-title":"Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy","volume":"21","author":"Piselli","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100818_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2009.11.018","article-title":"A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus","volume":"8","author":"Singal","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ijregi.2025.100818_bib0027","unstructured":"Laws of Brunei (Revision Edition 2023): Chapter 17 Immigration, https:\/\/www.agc.gov.bn\/AGC%20Images\/LAWS\/ACT_PDF\/I\/CAP%2017%20IMMIGRATION%20ACT.pdf; 2023 [accessed 06 November 2025]."},{"key":"10.1016\/j.ijregi.2025.100818_bib0028","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/hep.23002","article-title":"Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study","volume":"50","author":"Uto","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ijregi.2025.100818_bib0029","author":"Lim"},{"key":"10.1016\/j.ijregi.2025.100818_bib0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/jvh.12859","article-title":"Understanding and addressing hepatitis C reinfection in the oral direct-acting antiviral era","volume":"25","author":"Falade-Nwulia","year":"2018","journal-title":"J Viral Hepat"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625002528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625002528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:45:10Z","timestamp":1773913510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707625002528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"alternative-id":["S2772707625002528"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100818","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and control of hepatitis C virus infection in Brunei Darussalam: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100818"}}